319 filings
Page 4 of 16
CORRESP
6j8euoktjfprtb8izbr
19 Aug 21
Correspondence with SEC
12:00am
UPLOAD
ej8go3h
18 Aug 21
Letter from SEC
12:00am
8-K
6scnj8zit
13 Aug 21
Xenetic Biosciences, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update
8:05am
D
6t552477ftibj
3 Aug 21
$12.5M in equity / options / securities to be acquired, sold $12.5M, 1 investor
3:31pm
8-K
cm3zik
28 Jul 21
Xenetic Biosciences, Inc. Announces Closing of $12.5 Million Private Placement Priced at a Premium to Market
2:24pm
8-K
2ubk iplyftoi9
16 Jul 21
Departure of Directors or Certain Officers
4:30pm
8-K
0c5p1kwy iout6ka
12 May 21
Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results
7:00am
8-K
bo2xsi
17 Mar 21
Xenetic Biosciences, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
8:00am
8-K
5td0awqfzb1bk38
19 Jan 21
Regulation FD Disclosure
8:00am
8-K
lyl2334 8y
16 Dec 20
Other Events
9:00am
8-K
6m5z3jozgn2e
14 Dec 20
Xenetic Biosciences, Inc. Announces $6.0 Million Registered Direct Offering
11:15am
424B5
44bowad2
11 Dec 20
Prospectus supplement for primary offering
5:25pm
8-K
nsrcyook
9 Dec 20
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
575d4jnpq0ykgfw
13 Nov 20
Xenetic Biosciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Corporate Update
8:00am